Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Response Rate to Pre-Operative Docetaxel + Herceptin Study Part A and Docetaxel Study Part B in Locally Advanced Breast Cancer Patients, Stratified by HER2-Status Trial - PHASE II [(Herceptin Docetaxel Neoadjuvant) HEDON]

NCT00398489 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT00398489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00398489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Response Rate to Pre-Operative Docetaxel + Herceptin Study Part A and Docetaxel Study Part B in Locally Advanced Breast Cancer Patients, Stratified by HER2-Status Trial - PHASE II [(Herceptin Docetaxel Neoadjuvant) HEDON]
Lead sponsor
Technical University of Munich
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2006
Completion date
Not reported
Enrollment
94 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer